These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 788001)

  • 21. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
    Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
    Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multidimensional diagnostics in pharmacopsychiatry/results of therapy with desmethyl-loxapine (author's transl)].
    Bergener M; Escher HD; Linden KJ
    Arzneimittelforschung; 1976 Feb; 26(2):290-9. PubMed ID: 820358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two year trial of loxapine succinate in chronic psychotic patients.
    Simpson GM; Branchey MH; Lee JH; Varga E
    Dis Nerv Syst; 1976 May; 37(5):305-7. PubMed ID: 816626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open trial of buspirone added to neuroleptics in schizophrenic patients.
    Goff DC; Midha KK; Brotman AW; McCormick S; Waites M; Amico ET
    J Clin Psychopharmacol; 1991 Jun; 11(3):193-7. PubMed ID: 2066458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
    Pool D; Bloom W; Mielke DH; Roniger JJ; Gallant DM
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):99-104. PubMed ID: 812671
    [No Abstract]   [Full Text] [Related]  

  • 26. A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
    Paprocki J; Barcala Peixoto MP; Andrade NM
    Psychopharmacol Bull; 1976 Apr; 12(2):32-4. PubMed ID: 769026
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Wynchank D; Berk M
    Hum Psychopharmacol; 2003 Jun; 18(4):271-5. PubMed ID: 12766931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
    Henkel V; Mergl R; Schäfer M; Rujescu D; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 32. [Norepinephrine turnover under neuroleptic treatment of schizophrenic syndromes (author's transl)].
    Eben E; Ackenheil M; Rüther E
    Arzneimittelforschung; 1978; 28(9):1498. PubMed ID: 38809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loxapine (Loxitane).
    Med Lett Drugs Ther; 1975 Dec; 17(25):103. PubMed ID: 1105124
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
    Gaffney GR; Tune LE
    J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
    Gu SF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
    Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
    Moore DF
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):172-80. PubMed ID: 809232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.